A Randomized Study to Compare Efficacy Safety and Tolerability of Macitentan 75mg Versus Macitentan 10mg in Patients with Pulmonary Arterial Hypertension Followed by an Open-label Treatment Period with Macitentan 75mg

Brief description of study

TThe research study is being conducted to compare macitentan 75 mg with the approved macitentan 10 mg to see if it is well tolerated, safe and useful for treating patients with pulmonary arterial hypertension (PAH).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension
Age: Between 18 Years - 75 Years
Gender: All

Male and Female Age 18-76 pulmonary arterial hypertension (PAH).

Updated on 09 Mar 2024. Study ID: 848813

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).